CAD 0.09
(70.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | -100.0% |
2020 | 73.73 Thousand USD | -50.67% |
2019 | 149.46 Thousand USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | -100.0% |
2016 | 571.51 USD | 22.87% |
2015 | 465.15 USD | 56.16% |
2014 | 297.86 USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2024 Q2 | 30.75 Thousand USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2021 Q1 | 44.69 Thousand USD | -39.38% |
2021 FY | - USD | -100.0% |
2021 Q3 | - USD | -100.0% |
2021 Q4 | - USD | 0.0% |
2021 Q2 | 39.45 Thousand USD | -11.73% |
2020 Q1 | 144.42 Thousand USD | -3.37% |
2020 Q4 | 73.73 Thousand USD | -7.57% |
2020 Q3 | 79.77 Thousand USD | -24.68% |
2020 Q2 | 105.9 Thousand USD | -26.67% |
2020 FY | 73.73 Thousand USD | -50.67% |
2019 Q2 | 209.6 Thousand USD | -6.65% |
2019 FY | 149.46 Thousand USD | 0.0% |
2019 Q1 | 224.53 Thousand USD | 0.0% |
2019 Q4 | 149.46 Thousand USD | -14.69% |
2019 Q3 | 175.19 Thousand USD | -16.41% |
2018 Q4 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | 654.59 USD | 0.0% |
2017 FY | - USD | -100.0% |
2017 Q3 | 850.49 USD | 29.93% |
2017 Q4 | - USD | -100.0% |
2016 FY | 571.51 USD | 22.87% |
2016 Q3 | - USD | -100.0% |
2016 Q4 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q2 | 7729.29 USD | 0.0% |
2015 FY | 465.15 USD | 56.16% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 FY | 297.86 USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | - CAD | NaN% |
Asep Medical Holdings Inc | 20 Thousand CAD | 100.0% |
BetterLife Pharma Inc. | 245.23 Thousand CAD | 100.0% |
BioVaxys Technology Corp. | - CAD | NaN% |
ChitogenX Inc. | 3.87 Million CAD | 100.0% |
Rapid Dose Therapeutics Corp. | 2.45 Million CAD | 100.0% |
Defence Therapeutics Inc. | 1.74 Million CAD | 100.0% |
Entheon Biomedical Corp. | - CAD | NaN% |
Gemina Laboratories Ltd. | 285.32 Thousand CAD | 100.0% |
Glow Lifetech Corp. | 116.18 Thousand CAD | 100.0% |
Lexston Life Sciences Corp. | - CAD | NaN% |
Pharmala Biotech Holdings Inc. | 253.53 Thousand CAD | 100.0% |
Doseology Sciences Inc. | - CAD | NaN% |
MYND Life Sciences Inc. | 3 Million CAD | 100.0% |
Nova Mentis Life Science Corp. | - CAD | NaN% |
PharmaTher Holdings Ltd. | - CAD | NaN% |
PreveCeutical Medical Inc. | 3.83 Million CAD | 100.0% |
Telescope Innovations Corp. | - CAD | NaN% |